The number of samples in our study was limited and should be further increased, but the clear difference in the level and in the homogeneity of RACK1 expression between melanocytic cells in nevi and in cutaneous or metastatic melanoma suggests that RACK1 antigen could be used as a marker of malignancy in human melanocytic proliferation. This evidence concerns the gene RACK1 and metastatic melanoma.